American Medical Technologies Inc.
ADLI · OTC
12/31/2007 | 12/31/2006 | 12/31/2005 | 12/31/2004 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.05 | 0.09 | 0.00 | -1.90 |
| FCF Yield | -24.81% | -115.19% | -116.71% | -97.45% |
| EV / EBITDA | -2.12 | -1.08 | -1.80 | -2.38 |
| Quality | ||||
| ROIC | 275.72% | 317.58% | 73.04% | 56.24% |
| Gross Margin | 53.24% | 49.23% | 34.11% | 46.92% |
| Cash Conversion Ratio | 0.39 | 1.07 | 0.98 | -115.34 |
| Growth | ||||
| Revenue 3-Year CAGR | 13.87% | 6.99% | -10.34% | -37.14% |
| Free Cash Flow Growth | 74.32% | 4.29% | 54.12% | -467.71% |
| Safety | ||||
| Net Debt / EBITDA | -0.50 | -0.22 | -0.93 | -0.27 |
| Interest Coverage | 22.15 | 15.59 | 15.67 | 15.41 |
| Efficiency | ||||
| Inventory Turnover | 11.15 | 2.77 | 2.01 | 1.32 |
| Cash Conversion Cycle | -100.68 | -7.41 | 9.80 | 37.88 |